About
As a pioneer of quality antibiotics since its foundation in 1974, PT. Meiji Indonesia as a subsidiary of Meiji Seika Pharma Co.,Ltd. Japan, is currently one of the few players in this sector delivering highest production quality standards in Indonesia.
R&D Activities
Since its establishment in 1974, PT. Meiji Indonesia continues to research and develop quality products to meet the needs of Indonesia's domestic market as well as overseas markets such as Japan, Singapore, Thailand, and others. Our research and development activities not only focus on antibiotic products but we also do research and development on various products such as ethical prod ...
Welcome to the Website
On July 23 2022, PT Meiji Indonesia collaborated with SMEC to carry out the 22nd Maestro Lecture online. This activity is a routine activity from SMEC...
On July 23 2022, PT Meiji Indonesia collaborated with SMEC to carry out the 22nd Maestro Lecture online. This activity is a routine activity from SMEC...
On July 23 2022, PT Meiji Indonesia collaborated with SMEC to carry out the 22nd Maestro Lecture online. This activity is a routine activity from SMEC...
On July 23 2022, PT Meiji Indonesia collaborated with SMEC to carry out the 22nd Maestro Lecture online. This activity is a routine activity from SMEC...
On July 23 2022, PT Meiji Indonesia collaborated with SMEC to carry out the 22nd Maestro Lecture online. This activity is a routine activity from SMEC...
On July 23 2022, PT Meiji Indonesia collaborated with SMEC to carry out the 22nd Maestro Lecture online. This activity is a routine activity from SMEC...
On July 23 2022, PT Meiji Indonesia collaborated with SMEC to carry out the 22nd Maestro Lecture online. This activity is a routine activity from SMEC...